For example, recurrent isocitrate dehydrogenase (IDH) mutations are found in a number of cancers including myeloid malignancies and lower-grade gliomas (LGGs) [29,30] and establishes the CpG island methylator phenotype in glioma [31]. This evidence concerns the gene IDH1 and central nervous system cancer.